Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae. In adults it can present as pneumonia, blood infection (bacteraemia) or meningitis, all serious, sometimes fatal. Vaccines reduce these outcomes substantially, and Australia has updated its schedule in recent years to use newer, broader-coverage formulations.
Who is eligible under the NIP
- All adults aged 70 and over.
- Aboriginal and Torres Strait Islander adults aged 50 and over.
- Anyone aged 5 and over with specified medical risk conditions, splenectomy or asplenia, cochlear implants, immunocompromise, chronic lung or heart disease, and others. Eligibility is set out in the Handbook.
What about earlier vaccination?
Adults under 70 with no risk conditions can still receive pneumococcal vaccination privately. It is not routinely recommended in this age group, but for some people, frequent international travel, occupational exposure, or other considerations, it is sensible.
Schedule
Most adults need a single conjugate dose. Some risk groups receive a second polysaccharide dose at least 12 months later. Your immuniser will confirm the correct sequence based on your history.
Side-effect profile
Mostly local, soreness, redness, mild swelling. Some people feel tired or have low-grade fever for 24 hours. The 15-minute observation period applies.
Pneumococcal vaccination can be given at the same visit as your flu shot. Pull your record from myGov before the consult so we can confirm what you have already received.
Sources & further reading
General information only. This article is educational and is not a substitute for personal medical advice. Your immuniser will confirm eligibility and contraindications on the day.
TGA advertising compliance. Vaccines are referred to by disease or category in line with the Therapeutic Goods Advertising Code. Specific brands and registered indications are discussed at the consultation.